Page 4 - Biocon Stock

Sensex, Nifty end flat in choppy session; metals, auto, IT packs slip most

Stock market LIVE updates: The broader markets suffered more losses than the frontline indices. The BSE MidCap and SmallCap indices shed 0.5 and 0.7 per cent, respectively.

Stocks to watch: Tata Steel, HDFC, Jet Airways, JSW Steel, Biocon, PVR

Stocks to watch today: HDFC, slated to merge with HDFC Bank, raised Rs 4,000 crore through a paper with a maturity of 21 months; Jet Airways plans to lease 6 to 8 planes as part of re-launch.

Sensex snaps 4-day winning run, slips 150 pts; RIL gains 2%, Oil India 4.5%

CLOSING BELL: The Nifty IT, Bank, and FMCG indices dropped over 1 per cent each

Sensex gains for 3rd day, rises 433pts; Nifty holds 15,800; Zomato falls 6%

CLOSING BELL: Sectorally, the broad-based rally saw the Nifty Auto index ending with 2-per cent gain, and the Nifty Metal index with 1.6-per cent rally

Zomato, Dish TV, Biocon: Trading strategies for buzzing stocks of the day

Shares of Zomato face stiff resistance at Rs 78, while the downside support stays at Rs 60

Biocon slips 4% despite arm denying bribery charges

At 10:26 AM, the stock of Biocon was down 3 per cent at Rs 316.10, as compared to 1 per cent decline in the S&P BSE Sensex

Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months

Alembic Pharma and Dr Reddy's Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results

Stocks to watch: Nazara Tech, DRL, Adani Transmission, JSW Steel, Biocon

Pharma major Dr Reddy's Laboratories (DRL) expects the Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks, a company official has said

GMM Pfaudler, IDBI Bank: 14 Nifty500 stocks have surged above their 200-DMA

Analysts prefer stocks trading above the 200-DMA, since they tend to perform better in a trending market. Risk management, hence, becomes comparatively easier

Biocon tanks 10% on lower-than-expected December quarter results

Due to professional differences with the chairperson on strategic priorities and the vision for the company, Dr Christiane Hamacher has stepped down as the MD of Biocon Biologics

Stocks to watch: Wipro, 3i Infotech, Biocon, SBI Life, AU Small Finance

3i Infotech Ltd has entered into definitive agreements to sell its software products business to the funds advised by Apax Partners for Rs 1,000 crore

Biocon: Street to keep an eye on CY21 launches, market share gains

Launch of a cancer drug was delayed due to Covid-19

Biocon dips 11% in three days on disappointing September quarter results

The company said profitability was impacted on account of higher R&D expenses, staff costs, other expenses and forex losses

Multiple growth levers for Biocon; ramp-up, new biosimilars to boost profit

Ramp-up and new biosimilars should help boost profit

Biocon stock: Rich valuations, regulatory news flow may add to volatility

Analysts expect Biocon to gain 20-25 per cent market share and after factoring in a 20-25 per cent price erosion in the first year, they see its earnings improving to Rs 12-16